| HOME >> MEDICINE >> TECHNOLOGY |
20112010BasisBasisUnited States$
990$ 1,077(8)%(8)%EMEA
416
37810 %2 %Japan
235
21311 %0 %Inter-Continental
199
16917 %9 %International85076012 %3 %Subtotal Core Businesses1,8401,8370 %(3)%Divested Businesses
34
79N/AN/AWorldwide$ 1,874$ 1,916(2)%(6)%ChangeThree Months EndedAs ReportedConstantSeptember 30,CurrencyCurrencyin millions
20112010BasisBasisInterventional Cardiology
$
3
$
40 %(4)%Cardiac Rhythm Management
503
550(9)%(12)%Endoscopy
298
26911 %6 %Peripheral Interventions
182
1679 %4 %Urology/Women's Health
124
1222 %0 %Neuromodulation
84
796 %6 %Electrophysiology
36
360 %(2)%Subtotal Core Businesses1,8401,8370 %(3)%Divested Businesses
34
79N/AN/AWorldwide$ 1,874$ 1,916(2)%(6)%Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.
An explanation of the Company's use of these non-GAAP financial measures is provided at the end of this document.
BOSTON SCIENTIFIC CORPORATIONWORLDWIDE SALES
(Unaudited)ChangeNine Months EndedAs ReportedConstantSeptember 30,CurrencyCurrencyin millions
20112010BasisBasisUnited States$ 3,054$ 3,159(3)%(3)%EMEA
1,328
1,2486 %0 %Japan
705
6479 %(2)%Inter-Continental
576
49816 %8 %International2,6092,3939 %1 %Subtotal Core Businesses5,6635,5522 %(1)%Divested Businesses
111
252N/AN/AWorldwide$ 5,774$ 5,804(1)%(4)%ChangeNine Months EndedAs ReportedConstantSeptember 30,CurrencyCurrencyin millions
20112010BasisBasisInterventional Cardiology
$ 1,901
$ 1,961(3)%(7)%Cardiac Rhythm Management
1,606
1,615(1)%(4)%Endoscopy
883
79411 %6 %Peripheral Interventions
'/>"/>| SOURCE Boston Scientific Corporation Copyright©2010 PR Newswire. All rights reserved |